Luveris

DRUG4 trials

Sponsors

University of Saskatchewan, Peking University Third Hospital, Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany, Ellen Greenblatt

Conditions

Fertility PreservationHealthyInfertility

Phase 1

Pergoveris FD and Liquid China BE Study

CompletedNCT04899193

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, GermanyHealthy

Start: 2021-05-08End: 2022-05-28Updated: 2022-06-15

Phase 2

To Describe the Effect of rhLH Supplementation in Women With Hyporesponse to rhFSH After Pituitary Downregulation

Peking University Third HospitalInfertility

Start: 2009-12-31End: 2011-03-31Target: 150Updated: 2009-12-10

Phase 3

FSH and LH Versus FSH Alone for Ovarian Stimulation in Non-hormone Sensitive Onco-fertility Patients

Not yet recruitingNCT06227949

Ellen GreenblattFertility Preservation

Start: 2024-02-29End: 2031-12-31Target: 140Updated: 2024-01-29

Phase 4

Synchronization of Follicle Wave Emergence and Ovarian Stimulation

CompletedNCT00439829

University of SaskatchewanInfertility

Start: 2007-02-28End: 2010-05-31Target: 80Updated: 2010-05-25

Related Papers

Synchronization of ovarian stimulation with follicle wave emergence in patients undergoing in vitro fertilization with a prior suboptimal response: a randomized, controlled trial.

2012-07-2014 citations